A New Strategy for Discontinuation of Dual Antiplatelet Therapy-Reference-Cited by-同舟云学术

A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Published:2012-10 Issue:15 Volume:60 Page:1340-1348
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kim Byeong-Keuk,Hong Myeong-Ki,Shin Dong-Ho,Nam Chung-Mo,Kim Jung-Sun,Ko Young-Guk,Choi Donghoon,Kang Tae-Soo,Park Byoung-Eun,Kang Woong-Chol,Lee Seung-Hwan,Yoon Jung-Han,Hong Bum-Kee,Kwon Hyuck-Moon,Jang Yangsoo

Funder

Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs

Korea Health 21 R&D Project, Ministry of Health & Welfare

Medtronic

Cardiovascular Research Centers

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents;Iakovou;JAMA,2005

2. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents;Pfisterer;J Am Coll Cardiol,2006

3. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary

4. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial;Fajadet;Circulation,2006

5. Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study;Meredith;Am J Cardiol,2007

Cited by 585 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Patients with Chronic Coronary Syndromes;Interventional Cardiology Clinics;2024-10

2. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

3. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application;International Journal of Molecular Sciences;2024-07-10

4. Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis;Journal of the Society for Cardiovascular Angiography & Interventions;2024-07

5. Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry;Minerva Cardiology and Angiology;2024-06